Abstract:Objective This retrospective study investigated the prognostic significance and risk factors of benign pathologic types of background endometrium surrounding endometrial polyps (EPs). Methods We assessed 206 patients who underwent hysteroscopic polypectomy and background endometrium biopsy. Patients were categorized into four groups based on the pathologic types of background endometrium: normal proliferative endometrium (NPE), polypoid hyperplastic endometrium (PHE), chronic endometritis (CE), and non‐atypical endometrial hyperplasia (NEH). We employed univariable comparisons and multivariable logistic regression analysis to identify risk factors of PHE, CE, and NEH compared to NPE. Abnormal uterine bleeding (AUB) and recurrence of EPs were monitored over a 12‐month postoperative follow‐up period. Results Independent risk factors for EPs with a background of CE included a history of genital tract infection (OR = 8.88, 95% CI: 2.95–26.70, P = 0.000), adenomyosis (OR = 13.70, 95% CI: 3.38–55.52, P = 0.000), and hydrosalpinx (OR = 2.23, 95% CI: 1.59–54.09, P = 0.013). Age (OR = 1.18, 95% CI: 1.07–1.30, P = 0.001) and BMI (OR = 1.33, 95% CI: 1.11–1.61, P = 0.003) were significant risk factors for EPs with a background of NEH. Patients with PHE had higher recurrence rates of EPs following 12 months of follow‐up. Moreover, background endometrium types PHE, CE, and NEH were associated with poorer control of AUB. Conclusion Our study underscores the importance of examining the histopathologic characteristics of the background endometrium surrounding EPs, as these benign lesions significantly influence the recurrence and symptomatology of EPs.

Expression of estrogen receptor in the endometrial polyps in postmenopausal women and its clinical significance

Impact of estrogen and progesterone receptor expression on the incidence of endometrial polyps

The expression of estrogen receptor and progesterone receptor in endometrial polyps

The expression of estrogen and progesterone receptors in the endometrial polyps in postmenopausal women and its effect on therapy

A Comparison of Oestrogen Receptor and Progesterone Receptor Expression in Endometrial Polyps and Endometrium of Premenopausal Women

Clinical Characteristics of 42 Cases of Malignant Endometrial Polyps

Clinical Characteristics of Endometrial Polyps in Postmenopausal Women

Expression Of Vascular Endothelial Growth Factor And Insulin-Like Growth Factor-1 In Endometrial Polyps And Their Clinical Significance

Expressions of Bcl-2,estrogen Receptor(er)and Progesterone Receptor(pr) in Endometriosis and Eutopic Endometrium

Transcriptomic Analysis Reveals Intrinsic Abnormalities in Endometrial Polyps

Expression of Progesterone Receptor Subtypes in Ectopic Endometrium of Adenomyosis

Advances in the Pathogenesis of Endometrial Polyps

Expression of Estrogen and Progesterone Receptor Subtypes in Human Endometrial Carcinoma Tissues

Endometrial polyps in postmenopausal women: results of a comparative analysis of clinical features after hysteroscopic polypectomy

Expression of HOXA 11 in Human Endometrial Hyperplasia and Adenocarcinoma

Expression of Prostaglandin E2 Receptor Subtype in Endometrial Carcinoma

Expression of ER and PR in Ectopic and Eutopic Endometrium in Patients with Endomtriosis

[The Changes of Estrogen Receptor (ER) and Progesterone Receptor (PR) Mrnas in Endometrium with Endometriosis].

The risk factors and prognostic impact of different benign pathologic types of background endometrium surrounding endometrial polyps

Investigation Progress of Pathogenesis in Endometrial Polyps

The expression and methylation of PR-B in adenomyosis